NM_016356.5:c.123_124delGT
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_016356.5(DCDC2):c.123_124delGT(p.Ser42GlnfsTer72) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,613,384 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_016356.5 frameshift
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DCDC2 | NM_016356.5 | c.123_124delGT | p.Ser42GlnfsTer72 | frameshift_variant | Exon 1 of 10 | ENST00000378454.8 | NP_057440.2 | |
| DCDC2 | NM_001195610.2 | c.123_124delGT | p.Ser42GlnfsTer72 | frameshift_variant | Exon 2 of 11 | NP_001182539.1 | ||
| KAAG1 | NR_174942.1 | n.727_728delAC | non_coding_transcript_exon_variant | Exon 1 of 1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DCDC2 | ENST00000378454.8 | c.123_124delGT | p.Ser42GlnfsTer72 | frameshift_variant | Exon 1 of 10 | 1 | NM_016356.5 | ENSP00000367715.3 | ||
| DCDC2 | ENST00000436313.1 | c.24_25delGT | p.Ser9SerfsTer80 | frameshift_variant | Exon 1 of 3 | 3 | ENSP00000410939.1 | |||
| KAAG1 | ENST00000274766.2 | n.727_728delAC | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000161 AC: 4AN: 248076 AF XY: 0.0000149 show subpopulations
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461154Hom.: 0 AF XY: 0.0000179 AC XY: 13AN XY: 726892 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74380 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
Isolated neonatal sclerosing cholangitis Pathogenic:2
This sequence variant is a 2 nucleotide deletion (delGT) in the exon 1 of 10 of the DCDC2 gene that results in an early termination codon 72 amino acids downstream of the frameshift at codon 42. This variant is predicted to generate a non-functional allele through either the expression of a truncated protein or a loss of doublecortin domain containing 2 expression due to nonsense mediated decay. This is a previously reported variant (ClinVar 180688) that has been observed in both homozygous and compound heterozygous states in individuals affected by hepatic ciliopathy and neonatal sclerosing cholangitis (PMID: 25557784, 37296768, 27469900, 36938759). This variant is present in 5 of 400306 alleles (0.0012%) in the gnomAD population dataset. Functional studies have found that the protein resulting from this variant failed to properly localize in the primary cilium, did not interact with its protein partners, and could not rescue mouse kidney cells in which DCDC2 expression was knocked-down (PMID: 25557784). Based upon the evidence, we consider this variant to be pathogenic. ACMG Criteria: PM2, PS3, PVS1
Autosomal recessive nonsyndromic hearing loss 66;C4479344:Isolated neonatal sclerosing cholangitis Pathogenic:1
This sequence change creates a premature translational stop signal (p.Ser42Glnfs*72) in the DCDC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DCDC2 are known to be pathogenic (PMID: 27319779, 27469900). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 180688). This premature translational stop signal has been observed in individual(s) with DCDC2-related conditions (PMID: 25557784, 27469900). This variant is present in population databases (rs757704417, gnomAD 0.003%).
not provided Pathogenic:1
DNA sequence analysis of the DCDC2 gene demonstrated a 2 base pair deletion in exon 1, c.123_124del. This sequence change results in an amino acid frameshift and creates a premature stop codon 72 amino acids downstream of the change, p.Ser42Glnfs*72. This sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated DCDC2 protein with potentially abnormal function. This sequence change has been described in the gnomAD database with a frequency of 0.004% in the European (non-Finnish) subpopulation (dbSNP rs757704417). This pathogenic sequence change has previously been described in an individual with DCDC2-related disorders [PMID: 25557784]; in addition, other deletions/duplications in the DCDC2 gene have been described in several individuals with DCDC2-related disorders [PMID: 31821705, 25557784]. Functional studies in cell models of the p.Ser42Glnfs*72 sequence change demonstrate altered subcellular localization of the altered DCDC2 protein versus wild-type DCDC2 [PMID: 25557784]. These collective evidences indicate that this sequence change is pathogenic.
Autosomal recessive nonsyndromic hearing loss 66;C4015542:Nephronophthisis 19;C4479344:Isolated neonatal sclerosing cholangitis Pathogenic:1
Nephronophthisis 19 Pathogenic:1
Dyslexia, susceptibility to, 2 Pathogenic:1
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at